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The cytokine response to heavy exertion varies widely for unknown reasons, and this
study evaluated the relative importance of glycogen depletion, muscle damage, and
stress hormone changes on blood and muscle cytokine measures. Cyclists (N = 20)
participated in a 75-km cycling time trial (168 ± 26.0 min), with blood and vastus lateralis
muscle samples collected before and after. Muscle glycogen decreased 77.2 ± 17.4%,
muscle IL-6, IL-8, and MCP-1 mRNA increased 18.5 ± 2.8−, 45.3 ± 7.8−, and 8.25
± 1.75-fold, and muscle IL-6, IL-8, and MCP-1 protein increased 70.5 ± 14.1%, 347 ±
68.1%, and 148 ± 21.3%, respectively (all, P < 0.001). Serum myoglobin and cortisol
increased 32.1 ± 3.3 to 242 ± 48.3 mg/mL, and 295 ± 27.6 to 784 ± 63.5 nmol/L,
respectively (both P < 0.001). Plasma IL-6, IL-8, and MCP-1 increased 0.42 ± 0.07 to
18.5± 3.8, 4.07± 0.37 to 17.0± 1.8, and 96.5± 3.7 to 240± 21.6 pg/mL, respectively
(all P < 0.001). Increases in muscle IL-6, IL-8, and MCP-1 mRNA were unrelated to any
of the outcome measures. Muscle glycogen depletion was related to change in plasma
IL-6 (r = 0.462, P = 0.040), with change in myoglobin related to plasma IL-8 (r = 0.582,
P = 0.007) and plasma MCP-1 (r = 0.457, P = 0.043), and muscle MCP-1 protein (r =
0.588, P= 0.017); cortisol was related to plasma IL-8 (r = 0.613, P= 0.004), muscle IL-8
protein (r = 0.681, P = 0.004), and plasma MCP-1 (r = 0.442, P = 0.050). In summary,
this study showed that muscle IL-6, IL-8, and MCP-1 mRNA expression after 75-km
cycling was unrelated to glycogen depletion and muscle damage, with change in muscle
glycogen related to plasma IL-6, and changes in serum myoglobin and cortisol related
to the chemotactic cytokines IL-8 and MCP-1.
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INTRODUCTION
The cytokine response across a range of exercise workloads has been broadly described (Peake
et al., 2015). In general, intensive and sustained exercise bouts result in high plasma cytokine
concentrations when compared to more moderate activity, with the greatest fold changes measured
for IL-6, IL-8, IL-10, and granulocyte colony stimulating factor (G-CSF), interleukin-1 receptor
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antagonist (IL-1ra), and monocyte chemoattractant protein-
1 (MCP-1) (Nieman et al., 2003, 2005, 2006, 2007, 2012,
2014). Cytokine release during exercise assists in many
important physiological roles including control of inflammation
and immune cell movement, enhancement of lipolysis and
insulin sensitivity, and regulation of tissue repair and training
adaptations (Pedersen, 2013; Catoire and Kersten, 2015; Peake
et al., 2015).
The plasma cytokine response to prolonged and intensive
exercise varies widely between individuals, and the relative
importance of factors that explain this variance is still being
investigated (Peake et al., 2015). These may include pre-exercise
muscle glycogen levels and the rate of glycogen depletion
during exercise, the extent of muscle damage, the exercise mode
and workload, plasma stress hormone levels, medication use,
carbohydrate intake and nutritional status, environmental stress,
age, gender, and training status (Keller et al., 2001, 2003, 2005;
Nieman et al., 2003, 2004, 2005, 2006, 2009, 2012, 2014, 2015;
Chan et al., 2004; Holmes et al., 2004; Helge et al., 2011;
Reihmane et al., 2013; Della Gatta et al., 2014; Wright et al.,
2014).
Exercising with low muscle glycogen content has been related
to increased muscle IL-6 and IL-8 mRNA expression and
release (Keller et al., 2001; Steensberg et al., 2001; Chan et al.,
2004). Athletes vary widely in glycogen depletion rates during
prolonged and extensive exercise, and these studies imply that
those with the highest rates may experience the greatest muscle
cytokine mRNA expression. However, most investigators have
not been able to confirm this proposed relationship (Holmes
et al., 2004; Keller et al., 2005; Gusba et al., 2008; Helge et al.,
2011; Nieman et al., 2015). Our research group recently reported
that post-run muscle glycogen content was negatively related to
plasma but not muscle mRNA levels for IL-6, IL-8, and MCP-
1 in 24 male endurance athletes who ran to exhaustion on
treadmills at ∼70% VO2max (Nieman et al., 2015). Additionally,
no significant correlations were found between exercise-induced
changes in stress hormones and plasma ormuscle cytokines (both
mRNA and protein levels). Limitations in this study included the
lack of measurement of muscle damage, and a modest decrease
in muscle glycogen sampled from the runner’s vastus lateralis
(35%).
The purpose of this study was to correlate changes in
glycogen depletion (primary outcome), muscle damage, and
the stress hormone cortisol following 75-km of cycling with
changes in plasma cytokines, and muscle cytokine mRNA and
protein levels in 20 trained cyclists. Muscle samples were
biopsied from the vastus lateralis, a muscle that is more
directly involved in generating power during long endurance
cycling compared to running, and becomes more depleted in
glycogen (Nieman et al., 2003, 2005, 2015). We hypothesized
that significant, negative relationships would be measured
between variance in vastus lateralis glycogen depletion and
muscle IL-6, IL-8, and MCP-1 mRNA expression, change
in muscle cytokine protein concentrations, and increases in
plasma cytokine levels in cyclists after a 75-km cycling time
trial.
METHODS
Participants and Baseline Testing
Participant recruitment was conducted via direct messaging to
cyclists and cycling clubs in the Charlotte, NC, metropolitan area.
Participants included 20 male cyclists (ages 29–48 years) who
regularly competed in road races and had experience with long
distance cycling time trials. Participants voluntarily provided
informed consent and all study procedures were approved by the
Institutional Review Board at Appalachian State University.
One week prior to the 75-km time trial, each athlete completed
orientation/baseline testing. Demographic and training histories
were acquired with questionnaires. Maximal power, oxygen
consumption, ventilation, and heart rate were measured during
a graded exercise test (25W increase every 2 min, starting at
150W) with the Cosmed Quark CPET metabolic cart (Rome,
Italy) and the Lode cycle ergometer (Lode Excaliber Sport,
Lode B.V., Groningen, Netherlands). Body composition (whole
body fat percentage through air displacement plethysmography
technology) was measured with the Bod Pod body composition
analyzer (Life Measurement, Concord, CA).
Seventy Five-Kilometer Cycling Time Trial
One week following baseline testing, participants completed in
a 75-km cycling time trial on their own bicycles mounted on
CompuTrainer Pro Model 8001 trainers (RacerMate, Seattle,
WA). A mountainous 75-km course with moderate difficulty
was chosen and programmed into the software system. Heart
rate and rating of perceived exertion (RPE) were recorded
at 15min, and every 60 min thereafter, and workload in
watts was continuously monitored using the CompuTrainer
MultiRider software system (version 3.0). Oxygen consumption
and ventilation were measured using the Cosmed Quark
CPET metabolic cart (Rome, Italy) after 16 and 55 km cycling.
Participants were allowed to ingest water ad libitum during the
75-km cycling time trial, but intake of other beverages and food
were prohibited.
Blood Sample Analysis
Blood samples were collected 30min pre- and immediately post-
exercise and analyzed for plasma glucose, plasma lactate, serum
cortisol, serummyoglobin, and plasma cytokines. Plasma glucose
and lactate were analyzed using the YSI 2300 STAT Plus Glucose
and Lactate analyzer (Yellow Springs, OH).
Serum myoglobin was measured using an LX-20 clinical
analyzer (Beckman Coulter Electronics, Brea, CA). Serum
cortisol was analyzed with an electrochemiluminescence
immunoassay (ECLIA) through a commercial lab (LabCorp,
Burlington, NC). Total plasma concentrations of three cytokines
[monocyte chemoattractant protein-1 (MCP-1), IL-6, and IL-8]
were determined using an electrochemiluminescence based
solid-phase sandwich immunoassay (Meso Scale Discovery,
Gaithersburg, MD, USA). All samples and provided standards
were analyzed in duplicate, and the intra-assay CV ranged from
1.7 to 7.5% and the inter-assay CV 2.4 to 9.6% for all cytokines
measured. Pre-and post-exercise samples for the cytokines were
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analyzed on the same assay plate to minimize inter-kit assay
variability.
Muscle Biopsy Procedures
Muscle biopsy samples were acquired 30 min pre-exercise
and immediately post-exercise on the same leg at the same
vastus lateralis locations (2 cm apart). Local anesthesia
(1% xylocaine, Hospira, Inc., Lake Forest, IL) was injected
subcutaneously. After a small incision, a muscle biopsy
sample was obtained using the suction-modified percutaneous
needle biopsy procedure (Shanely et al., 2014). Muscle was
trimmed of connective tissue and fat and immediately
frozen in liquid nitrogen. Samples were stored at −80◦C
until subsequent analysis. A glycogen assay kit (Catalog
#MAK016, Sigma-Aldrich, St. Louis, MO) was used to determine
the concentration of glycogen in vastus lateralis muscle
homogenates. In this coupled enzyme assay, glucoamylase
hydrolyzed glycogen to glucose, and then the glucose was
oxidized to yield a product that reacted with a probe to
generate a color detectable with a microplate reader (Synergy
H1 Hybrid Reader, BioTek Instruments, Inc., Winooski, VT)
at 570 nm.
Muscle mRNA Measurements
Total RNA extraction of vastus lateralis biopsies was conducted
using an RNeasy R© Fibrous Tissue Mini Kit (Qiagen, Limburg,
Netherlands) according to the manufacturer’s instructions.
Frozen muscle biopsies were homogenized in RTL –β-
mercaptoethanol Buffer with a Precellys homogenizer
(Bertin Technologies, Montigny-le-Bretonneux, France).
An aliquot of RNA from all samples were run on 1.5
denaturing agarose gels stained with ethidium bromide
to confirm RNA integrity. Additionally, RNA quality was
further verified spectrophotometrically using the A260/A280
ratio which was determined using a nanodrop. Reverse
transcription of RNA into cDNA was conducted using a
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA) as per manufacturer’s instructions.
Reverse transcription was performed using a GeneAmp R© PCR
System 9700 (Applied Biosystems). cDNA was quantified
using a nanodrop and aliquots were stored at −20◦C
until Real Time-Polymerase Chain Reaction (RT-PCR)
analysis.
Quantitative RT-PCR analysis of messenger RNA (mRNA)
was conducted under pre-optimized TaqMan Gene Expression
Assays (Applied Biosystems) using gene specific FAM dye-
labeled primers for IL-6 (Cat. No. 4453320), IL-8 (Cat. No.
4369514), MCP-1 (Cat. No. 4331182) and beta-2-microglobulin
(B2M) (Cat. No. 4351370). Samples and reagents were loaded
in a MicroAmP Fast-Optical 96 Well Reaction Plate and run
in quadruplicate. Plates were analyzed on a 7500 Fast RT-
PCR System (Applied Biosystems). Relative mRNA levels were
determined using the 11Ct calculations with B2M serving as
the housekeeping gene (Livak and Schmittgen, 2001). Changes in
cytokine expression post exercise were normalized to pre-exercise
levels.
Analysis of Skeletal Muscle Inflammatory
Cytokine Protein Concentrations
Skeletal muscle biopsy samples were analyzed for the
inflammatory cytokines IL-6, IL-8, and MCP-1 with a magnetic
bead-based multiplex assay using the MAGPIX instrument
and xPONENT R© analysis software (Luminex, Austin, TX).
Briefly, ∼30mg of each skeletal muscle tissue biopsy sample was
homogenized in lysis buffer (Millipore, Billerica, MA; #43-040)
with AEBSF protease inhibitor added (Millipore; #101500).
Homogenates were cleared by centrifugation at 14,000 x g and
the protein concentration of the supernatant was determined
using a BCA protein assay kit (Pierce ThermoFisher, Rockford,
IL). Next, 30 µg of muscle protein was added to each well
(in duplicate) and the concentration of each cytokine was
measured using the MILLIPLEX R© MAP assay kit (Millipore,
#HCYTOMAG-60K) according to manufacturer’s specifications.
The lower limit of detection and inter-assay % coefficient of
variability (% CV) for this panel of analytes was: IL-6 = 0.17
pg/mL (4.2% CV); IL-8 = 0.18 pg/mL (5.9% CV); and MCP-1
= 0.30 pg/mL (3.0% CV). The intra-assay %CVs were IL-6 =
13.6%, IL-8= 8.9%, and MCP-1= 3.7%.
Statistical Analysis
Data are expressed as mean ± SD. Pre- and post-exercise
data were tested for change using paired t-tests, with Pearson
correlations used to test relationships between outcomemeasures
(alpha level P ≤ 0.05).
RESULTS
Table 1 summarizes participant characteristics for the 20 male
cyclists (age range, 29–48 years). The cyclists completed the 75-
km cycling time trial in 168 ± 26.0 min at a high metabolic
intensity or 69.6 ± 10.3% VO2max (Table 2). Participants
reported an RPE of 12.4 ± 1.5 at 15 min, 13.1 ± 1.5 at 60
min, 14.6 ± 1.8 at 120 min, and 17.6 ± 0.7 (“very hard”) at the
end of the 75-km cycling trial (average of 14.7 ± 1.6 for the
entire time trial). Serum cortisol increased 196 ± 129%, serum
myoglobin 794 ± 1025%, and plasma lactate 125 ± 29.3%, with
no significant change in plasma glucose, by the end of the 75-km
TABLE 1 | Participant characteristics (N = 20 male cyclists).
Variable Mean ± SD
Age 38.4± 6.0
Height (m) 1.82± 0.7
Weight (kg) 83.3± 7.2
Body fat (%) 20.3± 5.9
VO2max (ml
.kg−1min−1) 47.9± 7.8
Maximal heart rate (beats/min) 179± 8.6
Wattsmax 351± 57.6
Maximal ventilation (L/min) 128± 17.1
Maximal respiratory rate (breaths/min) 46.7± 7.4
Training (km/week) 154± 93.5
SD, standard deviation; VO2max , maximal oxygen consumption.
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TABLE 2 | Performance variables averaged for entire 75 km cycling time
trial (N = 20 male cyclists).
Variable mean ± SD
VO2 (ml
.kg−1min−1) 33.2±6.4
%VO2max 69.6±10.3
Watts 193±57.8
%Wattsmax 54.2±9.6
HR (beats/min) 160±11.5
%HRmax 89.4±5.9
Ventilation (L/min) 74.0±16.7
Rating Perceived Exertion (RPE) 14.7±1.6
SD, standard deviation; VO2, oxygen consumption; VO2max , maximal oxygen
consumption; HR, heart rate.
TABLE 3 | Cortisol, myoglobin, lactate, and glucose concentrations from
blood samples in N = 20 male cyclists (mean ± SD).
Variable Pre-75 km
cycling
Post-75-km
cycling
P-value
Serum cortisol (µg/dL) 10.7±4.3 28.4± 10.5 <0.001
Serum myoglobin (ng/mL) 32.1±14.7 242± 216 <0.001
Plasma lactate (mmol/L) 0.97±0.3 2.02± 1.0 <0.001
Plasma glucose (mmol/L) 3.88±0.78 4.25± 0.75 0.185
P-value from paired t-test.
cycling time trial (Table 3). Muscle glycogen decreased 77.2 ±
17.4% (Figure 1), with an absolute change of 71.4 ± 23.1 (range
32–110) mmol glycogen per kilogram wet weight of muscle (P <
0.001).
Muscle IL-6, IL-8, and MCP-1 mRNA increased 18.5± 2.8-,
45.3 ± 7.8-, and 8.25 ± 1.75-fold, respectively, all P < 0.001
(Figure 2). Muscle IL-6, IL-8, and MCP-1 protein increased 70.5
± 14.1%, 347 ± 68.1%, and 148 ± 21.3%, respectively, all P <
0.001 (Figure 3). Plasma IL-6, IL-8, and MCP-1 increased from
0.42 ± 0.07 to 18.5 ± 3.8, 4.07 ± 0.37 to 17.0 ± 1.8, and 96.5 ±
3.7 to 240± 21.6 pg/mL, respectively, all P< 0.001 (Figures 4, 5).
Performance measures (time, %wattsmax), and changes in
muscle glycogen, serum myoglobin, serum cortisol, and plasma
IL-6, IL-8, and MCP-1 were unrelated to change in muscle IL-6,
IL-8, and MCP-1 mRNA. Muscle glycogen change was related to
change in plasma IL-6 (r=−0.462, P= 0.040), with relationships
found for serum myoglobin with plasma IL-8 (r = 0.582, P =
0.007) and plasma MCP-1 (r = 0.457, P = 0.043), and muscle
MCP-1 protein (r= 0.588, P= 0.017). Serum cortisol was related
to plasma IL-8 (r = 0.613, P = 0.004) and plasma MCP-1 (r =
0.442, P= 0.050), andmuscle IL-8 protein (r= 0.681, P= 0.004).
DISCUSSION
Twenty well-trained male cyclists engaged in a 75-km cycling
time trial and experienced an average decrease of approximately
three-fourths of glycogen content in the vastus lateralis, and
significant increases in the muscle damage biomarker serum
myoglobin (794%) and the stress hormone serum cortisol
FIGURE 1 | Pre- and post-75-km cycling skeletal muscle glycogen
levels in N = 20 cyclists.
(196%). Large post-exercise increases were measured in muscle
IL-6, IL-8, and MCP-1 mRNA expression and protein levels, and
plasma levels of these three cytokines. As expected, the decrease
in vastus lateralis glycogen content following 75-km cycling was
more than twice as great asmeasured following treadmill running
to exhaustion (Nieman et al., 2015).
Pre-to-post-exercise changes in all of these cytokine measures
varied widely between study participants as indicated by the
large standard deviations. For example, the increase in plasma
IL-6 varied from 2.7 to 73.6 pg/mL, with fold change for
IL-6 mRNA varying from 3.1 to 42.6. This purpose of this
study was to determine if the extent of muscle glycogen
depletion, muscle damage, and increase in serum cortisol
predicted some of the variance measured in exercise-induced
increases in plasma and muscle IL-6, IL-8, and MCP-1.
Contrary to our hypothesis, change in muscle glycogen was
not related to increases in muscle IL-6, IL-8, and MCP-1
mRNA and protein levels, or plasma IL-8 and MCP-1. A
modest correlation was measured between changes in muscle
glycogen and plasma IL-6, in agreement with our previous,
similar study in runners (Nieman et al., 2015). Exercise-induced
elevations in the muscle damage biomarker serum myoglobin
and serum cortisol both correlated with increases in plasma
levels of two chemotactic cytokines, IL-8 and MCP-1, with
additional linkages to muscle MCP-1 and IL-8 protein content,
respectively.
A strength of this study was the simultaneous measurement
of muscle mRNA expression, muscle protein content, and plasma
levels for three cytokines (IL-6, IL-8, andMCP-1) after exhaustive
exercise (Nieman et al., 2015). Della Gatta et al. (2014) reported
that muscle mRNA expression and protein content for IL-6, IL-8,
and MCP-1 were increased 2 h following intensive leg resistance
exercise. Data also supported the novel finding that exercise-
induced cytokine release may have originated from cells in the
interstitial space between muscle fibers, including macrophages,
satellite cells, and other stromal cells. In the current study, the
magnitude of increase in muscle IL-6, IL-8, and MCP-1 mRNA
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FIGURE 2 | Fold change in skeletal muscle mRNA expression for IL-6,
IL-8, and MCP-1 in N = 20 cyclists in response to 75-km cycling.
FIGURE 3 | Percent change in skeletal muscle cytokine protein content
for IL-6, IL-8, and MCP-1.
expression and protein content was substantially higher in the
cyclists after 75-km cycling (168 ± 26.0 min, 69.6 ± 10.3%
VO2max) compared to our prior study with runners following a
treadmill run to exhaustion (144± 6.5 min, 69.2± 6.4%VO2max)
(Nieman et al., 2015). The increase in plasma IL-6, IL-8, and
MCP-1, however, was very similar between these two studies.
These data from studies conducted in our Human Performance
Laboratory with cyclists and runners raise several interesting
issues and observations.
Obviously cycling and running have very different metabolic
demands on the vastus lateralis muscle, and biopsy samples
from this single muscle site provide data with certain limitations
when comparing exercise modes and corresponding cytokine
responses. There is growing support that multiple cells sources
from within skeletal muscle tissue, adipose tissue, and other
tissue areas produce cytokines in response to exercise workload
challenges (Peake et al., 2015). Thus, a limitation in the
FIGURE 4 | Pre- and post-exercise plasma IL-6 and IL-8
concentrations.
FIGURE 5 | Pre- and post-exercise plasma MCP-1 concentrations.
current study was the lack of fat biopsy samples that would
have improved interpretation of the muscle and plasma
data. Endothelial cells, pericytes, fibroblasts, neutrophils, and
monocytes/macrophages may all contribute to global cytokine
expression within multiple tissue areas of the human body
during prolonged and intensive exercise. In addition to skeletal
muscle, IL-6 is also released from the brain (Nybo et al., 2002),
peritendinous tissue (Langberg et al., 2002), and fat tissue (Keller
et al., 2003) during exercise. The net effect, whether the athlete
is engaging in long duration running or cycling, is an increase
in plasma IL-6, IL-8, MCP-1, and other cytokines that assist
physiological, metabolic, and immune processes within the body
to cope with the physiological stress (Pedersen, 2013; Catoire and
Kersten, 2015; Peake et al., 2015).
In this study in cyclists, and our previous study in runners,
we have been unable to link the wide variance in exercise-
induced glycogen depletion with cytokine mRNA expression in
skeletal muscle tissue. Our data indicate that vastus lateralis
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muscle glycogen depletion was more than twice as great in the
cycling compared to running study, and in both studies was
unrelated to muscle IL-6, IL-8, and MCP-1 mRNA expression
(Nieman et al., 2015). Plasma IL-6, IL-8, and MCP-1 levels were
negatively related to post-run glycogen levels in the running
study, with this relationship seen solely for plasma IL-6 in
the cycling study. Together these data indicate that muscle
glycogen depletion at best represents just one potential signal
for cytokine mRNA expression and production, and that other
factors have the potential to influence this relationship. For
example, we have previously shown that carbohydrate compared
to placebo ingestion during prolonged and intensive exercise is
related to elevated blood glucose levels, lower serum cortisol
and plasma epinephrine concentrations, and decreased muscle
mRNA expression and plasma levels for IL-6 and IL-8 despite
similar muscle glycogen depletion rates (Nieman et al., 2003,
2005). Others have shown that IL-6 release is markedly higher
from the arm compared with the leg during whole-body exercise,
and is not linked to muscle glycogen content (Helge et al.,
2011). In general, when endurance athletes engage in prolonged,
intensive exercise with normal pre-exercise glycogen levels,
depletion in muscle glycogen stores varies widely between and
typically cannot be linked to muscle IL-6, IL-8, or MCP-1 mRNA
expression, with some linkage to increases in plasma cytokine
levels (Nieman et al., 2003, 2005, 2015; Holmes et al., 2004; Gusba
et al., 2008; Helge et al., 2011).
This study included pre- and post-exercise serum myoglobin,
a rapid indicator of exercise-induced muscle damage. The
mountainous 75-km cycling course caused a significant increase
in serum myoglobin concentrations, but this varied widely
between the athletes (53–972 ng/ml). We showed that changes
in myoglobin were related to increases in plasma levels of two
chemotactic cytokines, IL-8 and MCP-1, and muscle MCP-1
concentrations. At the 160-km Western States Endurance Run
(WSER), we reported a strong relationship between the muscle
damage biomarker creatine kinase (CK), delayed onset of muscle
soreness (DOMS), and a spectrum of systemic inflammation
markers including IL-6, IL-8, MCP-1, C-reactive protein (CRP),
granulocyte colony stimulating factor (GCSF), IL-1 receptor
antagonist (IL-1ra), and IL-10 (Nieman et al., 2006, 2007;
Nieman, 2009). During the week following the WSER, DOMS
also showed modest positive correlations with many of the
cytokines changes experienced during the race (Nieman, 2009).
We also reported that muscle damage, muscle soreness, and
plasma cytokine levels were linked in a study using a 3-day
functional overreaching model (Nieman et al., 2014). Other
studies provide variable support for the linkage between muscle
damage and plasma cytokine levels, and this may be related
in part to the employment of exercise protocols that did not
combine the duration and intensity needed to induce sizeable
increases in outcome measures (Nieman et al., 2005; Peake et al.,
2005; Suzuki et al., 2006; Paulsen et al., 2012; Sugama et al.,
2012). The control of cytokine production in skeletal muscle
during exercise is complex and likely depends on interactions
between a wide variety of local and systemic factors (Peake et al.,
2015).
In summary, this study evaluated relationships of three
physiologic stress indicators (muscle glycogen depletion, acute
muscle damage, elevated levels of the stress hormone cortisol)
with increases of three cytokines (IL-6, IL-8, and MCP-1) in two
matrixes (muscle and plasma) measured in three ways (muscle
mRNA expression and protein content, plasma concentrations)
in athletes before and immediately after prolonged and intensive
exercise (75-km cycling on an intensive, mountainous course).
Although this study design is unique, additional blood and
muscle samples collected during recovery may have added
valuable data. However, this limitation must be balanced against
the rapid resolution of post-exercise plasma cytokine levels to
pre-exercise levels. Within this context, the data indicated that
increases in muscle IL-6, IL-8, and MCP-1 mRNA after 75-
km cycling were unrelated to glycogen depletion and muscle
damage. Modest relationships were seen between change in
muscle glycogen and increases in plasma IL-6, and changes in
serum myoglobin and cortisol to the chemotactic cytokines IL-8
and MCP-1.
In general, this study indicates that muscle glycogen depletion,
muscle damage, and increases in serum cortisol during intensive
and prolonged cycling are weak predictors of the strong but
highly variable post-exercise increase in plasma and muscle IL-
6, IL-8, and MCP-1 concentrations. In other words, 75-km of
cycling is a major “trigger” for muscle and plasma IL-6, IL-8, and
MCP-1 increases, but individual athletes vary widely for reasons
that are not explained by the extent of muscle glycogen depletion,
muscle damage, and increase in serum cortisol. In practical
terms, some athletes performing a 75-km cycling time trial may
experience high levels of inflammation compared to others, and
future research is needed to discover what best predicts this
variance in inflammation and potential influences on recovery.
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